---
title: "Agilent Technologies, Inc. (A.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/A.US.md"
symbol: "A.US"
name: "Agilent Technologies, Inc."
industry: "Life Sciences Tools and Services"
datetime: "2026-05-19T17:48:07.481Z"
locales:
  - [en](https://longbridge.com/en/quote/A.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/A.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/A.US.md)
---

# Agilent Technologies, Inc. (A.US)

## Company Overview

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems.

| Item | Detail |
|------|--------|
| Industry | Life Sciences Tools and Services |
| Exchange | US Market |
| Website | [www.agilent.com](https://www.agilent.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: B
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-19T04:30:14.000Z

**Overall: B (0.37)**

**Industry**: Life Sciences Tools and Services

| Metric | Value |
|--------|-------|
| Industry Ranking | 2 / 59 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Large - The company has stable operations, allowing for dependable long-term returns.

**Multi Score**: B

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 8.14% |  |
| Net Profit YoY | 2.46% |  |
| P/B Ratio | 4.59 |  |
| Dividend Ratio | 0.90% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 31682545758.87 |  |
| Revenue | 7065000000.00 |  |

#### Multi Score Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 19.95% | A |
| Profit Margin | 18.26% | A |
| Gross Margin | 52.89% | B |
| Revenue YoY | 8.14% | C |
| Net Profit YoY | 2.46% | C |
| Total Assets YoY | 7.55% | B |
| Net Assets YoY | 14.62% | B |
| Cash Flow Margin | 108.22% | C |
| OCF YoY | 8.14% | C |
| Turnover | 0.57 | B |
| Gearing Ratio | 46.09% | C |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Agilent Technologies, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "8.14%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "2.46%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "4.59",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.90%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "31682545758.87",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "7065000000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "19.95%",
          "rating": "A"
        },
        {
          "name": "Profit Margin",
          "value": "18.26%",
          "rating": "A"
        },
        {
          "name": "Gross Margin",
          "value": "52.89%",
          "rating": "B"
        },
        {
          "name": "Revenue YoY",
          "value": "8.14%",
          "rating": "C"
        },
        {
          "name": "Net Profit YoY",
          "value": "2.46%",
          "rating": "C"
        },
        {
          "name": "Total Assets YoY",
          "value": "7.55%",
          "rating": "B"
        },
        {
          "name": "Net Assets YoY",
          "value": "14.62%",
          "rating": "B"
        },
        {
          "name": "Cash Flow Margin",
          "value": "108.22%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "8.14%",
          "rating": "C"
        },
        {
          "name": "Turnover",
          "value": "0.57",
          "rating": "B"
        },
        {
          "name": "Gearing Ratio",
          "value": "46.09%",
          "rating": "C"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 24.56 | 7/59 | 31.75 | 29.02 | 25.90 |
| PB | 4.59 | 41/59 | 6.13 | 5.52 | 4.93 |
| PS (TTM) | 4.48 | 35/59 | 5.82 | 5.15 | 4.76 |
| Dividend Yield | 0.90% | 2/59 | 0.86% | 0.80% | 0.70% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | ChromaDex (CDXC.US) | A | A | A | B | A | A |
| 02 | Agilent Tech (A.US) | A | C | B | C | C | B |
| 03 | West Pharmaceutical (WST.US) | B | B | B | B | B | B |
| 04 | Illumina (ILMN.US) | A | C | B | D | C | B |
| 05 | WuXi Biologics (WXXWY.US) | B | B | C | A | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-17T04:00:00.000Z

Total Analysts: **17**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 10 | 59% |
| Overweight | 4 | 24% |
| Hold | 3 | 18% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 111.67 |
| Highest Target | 185.00 |
| Lowest Target | 140.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/A.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/A.US/norm.md)
- [Related News](https://longbridge.com/en/quote/A.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/A.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**